CN103230409A - Medicine for treating intestinal diseases and application - Google Patents
Medicine for treating intestinal diseases and application Download PDFInfo
- Publication number
- CN103230409A CN103230409A CN2013101710323A CN201310171032A CN103230409A CN 103230409 A CN103230409 A CN 103230409A CN 2013101710323 A CN2013101710323 A CN 2013101710323A CN 201310171032 A CN201310171032 A CN 201310171032A CN 103230409 A CN103230409 A CN 103230409A
- Authority
- CN
- China
- Prior art keywords
- injection
- medicine
- troxerutin
- calcium lactate
- citicoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for treating intestinal diseases. The medicine is prepared by the raw materials in parts by weight as follows: 1-3 parts of nicholin injection, 1-2.5 parts of troxerutin injection and 1-4 parts of calcium lactate injection, wherein the nicholin injection comprises 5.0g of nicholin in every 100ml of injection; the troxerutin injection comprises 5.0g of troxerutin in every 100ml of injection; and the calcium lactate injection comprises 5.0g of calcium lactate in every 100ml of injection. The medicine is used to treat non-specific colonitis and intestinal obstruction. The medicine disclosed by the invention has the complete effect of non-surgical treatment for treating intestinal obstruction and non-specific colonitis, and the cure rate is higher than 90%.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of intestinal tract disease.
Background technology
Nonspecific colonitis is decided to be difficult disease by domestic and international medical profession, the sickness rate height of this disease, and do not have specific drug both at home and abroad.
Intestinal obstruction disease, data record mortality rate be more than 25%, and various big hospital all adopts operative treatment, and the recurrence after operation rate is high, is called as adhesive ileus, is tormenting patient, has consumed a large amount of medical resources simultaneously again.
Summary of the invention
The present invention is directed to the deficiencies in the prior art, a kind of medicine for the treatment of intestinal tract disease is provided.
For achieving the above object, the technical solution used in the present invention is:
A kind of medicine for the treatment of intestinal tract disease, by following raw material by volume a part proportioning make:
1 ~ 3 part of citicoline injection
1 ~ 2.5 part of troxerutin injection
1 ~ 4 part of calcium lactate injection
Described citicoline injection is to contain citicoline 5.0g in every 100ml injection;
Described troxerutin injection is to contain troxerutin 5.0g in every 100ml injection;
Described calcium lactate injection is to contain calcium lactate 5.0g in every 100ml injection, and the preparation method of calcium lactate injection is: take by weighing the 5.0g calcium lactate and be dissolved in 100 ml physiological salines.
The application of above-mentioned medicine in treatment nonspecific colonitis and intestinal obstruction.
Beneficial effect of the present invention: medicine of the present invention is obtained the satisfactory effect of non-operative treatment in treatment intestinal obstruction and nonspecific colonitis, cure rate is higher than 90%.
A kind of medicine for the treatment of intestinal tract disease of the present invention is used for the treatment of ileac clinical setting:
(1) physical data:
Intestinal obstruction patient's 100 examples, wherein: male's 45 examples, women's 55 examples; 92 years old the highest age, 12 years old minimum age.
(2) diagnostic criteria:
Symptom: 1. paroxysmal abdominal pain increases the weight of gradually around the umbilicus;
2. vomiting;
3. abdominal distention;
4. defecation and aerofluxus are ended;
5. General Symptoms: thirsty, oliguria, rapid pulse are accelerated, irritated, shock.
Have a medical check-up: after blocking 4 ~ 6 hours, X-ray is clapped plain abdominal radiograph, and upright position sees that the multiple fluid level of enteric cavity is the ladder sample and changes.
Diagnostic criteria: possess three in the above-mentioned symptom, and the visible positive bit slice of abdominal part X-ray has the fluid level person to make a definite diagnosis.
(3) Therapeutic Method:
Get citicoline injection 2 ~ 6ml respectively, wherein contain citicoline 5.0g in per 100 ml citicoline injection, troxerutin injection 2 ~ 5ml, wherein contain troxerutin 5.0g in every 100ml troxerutin injection, calcium lactate injection 2 ~ 8ml wherein contains calcium lactate 5.0g in every 100ml calcium lactate injection, joins 250 milliliters of grades after three kinds of injection are mixed and oozes in glucose or the normal saline, vein input every day is once used 15 ~ 20 days continuously.
(4) efficacy assessment standard:
Cure: General Symptoms disappears, and defecation is unobstructed, no abdominal distention, stomachache, and X-ray is clapped the flat sign of normotopia plain abdominal radiograph liquid and is disappeared.
Take a turn for the better: vomiting disappears, a small amount of defecation of energy, and aerofluxus, other symptom is not complete obiteration as yet.
Invalid: clinical symptoms does not have improvement, and as seen the X-ray film making still has the fluid level sign.
(5) therapeutic outcome:
A kind of medicine for the treatment of intestinal tract disease of the present invention is used for the treatment of the clinical setting of nonspecific colonitis:
(1) physical data:
Nonspecific colonitis patient 100 examples, male: 72 examples; Women: 28 examples; 30 ~ 54 years old age.
(2) diagnostic criteria:
Symptom: 1. chronic diarrhea every day 3 ~ 20 times;
2. in the feces mucus is arranged;
3. hemafecia;
4. multidigit is in the left lower abdomen spasmodic colic;
5. malaise, become thin, anemia;
6. obstipation (keeping defecation by cathartic).
Have a medical check-up: colonoscope can be seen colon district myxedema, hyperemia, petechia or polyp, ulcer;
Standard is made a definite diagnosis in diagnosis: above-mentioned symptom possesses three, in conjunction with the colonoscopy report, can make a definite diagnosis simultaneously.
(3) Therapeutic Method:
Get citicoline injection 2 ~ 6ml respectively, wherein contain citicoline 5.0g in per 100 ml citicoline injection, troxerutin injection 2 ~ 5ml, wherein contain troxerutin 5.0g in every 100ml troxerutin injection, calcium lactate injection 2 ~ 8ml wherein contains calcium lactate 5.0g in every 100ml calcium lactate injection, joins 250 milliliters of grades after three kinds of injection are mixed and oozes in glucose or the normal saline, vein input every day is once used 15 ~ 20 days continuously.
(4) efficacy assessment standard:
Cure: symptom all disappears, the no abnormal report of colonoscopy.
Take a turn for the better: the stool molding, hemafecia disappears, and just subnormal, other symptom is not complete obiteration as yet.
Invalid: and change (symptom, coherence check) than no any improvement before going to a doctor.
(5) therapeutic outcome:
The specific embodiment
1 one kinds of medicines for the treatment of intestinal tract disease of embodiment, by following raw material by volume a part proportioning make:
1 part of citicoline injection
1 part of troxerutin injection
1 part of calcium lactate injection
Described citicoline injection is to contain citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is to contain troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is to contain calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
2 one kinds of medicines for the treatment of intestinal tract disease of embodiment, by following raw material by volume a part proportioning make:
3 parts of citicoline injection
1 part of troxerutin injection
2 parts of calcium lactate injection
Described citicoline injection is to contain citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is to contain troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is to contain calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
3 one kinds of medicines for the treatment of intestinal tract disease of embodiment, by following raw material by volume a part proportioning make:
1 part of citicoline injection
2.5 parts of troxerutin injection
4 parts of calcium lactate injection
Described citicoline injection is to contain citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is to contain troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is to contain calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
Claims (2)
1. medicine for the treatment of intestinal tract disease, it is characterized in that by following raw material by volume a part proportioning make:
1 ~ 3 part of citicoline injection
1 ~ 2.5 part of troxerutin injection
1 ~ 4 part of calcium lactate injection
Described citicoline injection is to contain citicoline 5.0g in every 100ml injection;
Described troxerutin injection is to contain troxerutin 5.0g in every 100ml injection;
Described calcium lactate injection is to contain calcium lactate 5.0g in every 100ml injection.
2. the application of the described medicine of claim 1 in treatment nonspecific colonitis and intestinal obstruction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171032.3A CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171032.3A CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103230409A true CN103230409A (en) | 2013-08-07 |
| CN103230409B CN103230409B (en) | 2014-12-31 |
Family
ID=48878527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310171032.3A Active CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103230409B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420773A (en) * | 2016-12-21 | 2017-02-22 | 郑州莉迪亚医药科技有限公司 | Chinese and western medicinal composition for treating radioactive enteritis, and preparation method and application thereof |
| US10898514B2 (en) * | 2018-01-12 | 2021-01-26 | Metimedi Pharmaceuticals Co., Ltd. | Methods of treating chronic inflammatory diseases |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1663569A (en) * | 2004-03-06 | 2005-09-07 | 杨喜鸿 | Fructose injection for cardiovascular medicine |
| CN101019854A (en) * | 2006-02-16 | 2007-08-22 | 北京奇源益德药物研究所 | Compound coenzyme Q10 medicine prepn and its prepn process and application |
-
2013
- 2013-05-10 CN CN201310171032.3A patent/CN103230409B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1663569A (en) * | 2004-03-06 | 2005-09-07 | 杨喜鸿 | Fructose injection for cardiovascular medicine |
| CN101019854A (en) * | 2006-02-16 | 2007-08-22 | 北京奇源益德药物研究所 | Compound coenzyme Q10 medicine prepn and its prepn process and application |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420773A (en) * | 2016-12-21 | 2017-02-22 | 郑州莉迪亚医药科技有限公司 | Chinese and western medicinal composition for treating radioactive enteritis, and preparation method and application thereof |
| US10898514B2 (en) * | 2018-01-12 | 2021-01-26 | Metimedi Pharmaceuticals Co., Ltd. | Methods of treating chronic inflammatory diseases |
| US11684635B2 (en) | 2018-01-12 | 2023-06-27 | Metimedi Pharmaceuticals Co., Ltd. | Methods of treating chronic inflammatory diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103230409B (en) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780254B (en) | Traditional Chinese medicine compound for treating intestinal tumor | |
| CN103230409B (en) | Medicine for treating intestinal diseases and application | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN102697771A (en) | New application of alpinetin | |
| CN101036732B (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
| CN103156961B (en) | Medicine composition used for treating common cold, wind cold, and lung and stomach heat stagnation | |
| CN102362897B (en) | Use of Hulisan Jiaonang in preparation of medicine for treating scabies | |
| CN106937987A (en) | Self-emulsifying eicosapentaenoic acid nutrient composition and its application | |
| CN1857563A (en) | Colon locating administrated dragon's blood preparation and its application | |
| CN100355436C (en) | Tibetan medicine for treating women's diseases, and its preparing method | |
| CN103566225B (en) | Medicament for treating gynecological postoperative gastrointestinal dysfunction | |
| CN102755456A (en) | Traditional Chinese medicine formula and capsule for dissolving kidney stone | |
| CN103877533B (en) | Pharmaceutical composition of a kind for the treatment of diabetes containing metformin and preparation method thereof | |
| CN106852932A (en) | A kind of medicine for treating cirrhotic ascites | |
| CN101357218B (en) | Externally used medicine for treating diabetes and preparation method thereof | |
| CN102406728B (en) | Medicinal composition for treating lymphaden inflammations | |
| CN101264268B (en) | Proprietary Chinese medicine for treating tumor | |
| CN106389439A (en) | Chinese and western medicine composition for curing liver cirrhosis ascites, and preparation method and application thereof | |
| CN101480383A (en) | Application of disodium sulfodehydroabietate for treating gastroxia type peptic ulcer and gastrointestinal tract inflammation | |
| CN105853940A (en) | Traditional Chinese medicine for treating bile disease | |
| Devi et al. | Management of Artava Kshaya with Venuparvadi Kwatha: A Clinical Study | |
| Sachdeva et al. | Abdominal Pain (Constipation) | |
| CN117045756A (en) | Traditional Chinese medicine composition and medical application thereof | |
| Su | Clinical Analysis of 12 Cases of Colon Cancer Postsurgical Gastric Paralysis | |
| CN106309585B (en) | A kind of Chinese medicine composition improving tumor patient ostalgia and its application in analgesia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |